nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0713	0.152	CbGbCtD
Irbesartan—CYP1A2—Leflunomide—rheumatoid arthritis	0.0515	0.11	CbGbCtD
Irbesartan—CYP2C9—Leflunomide—rheumatoid arthritis	0.0464	0.0993	CbGbCtD
Irbesartan—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.033	0.0706	CbGbCtD
Irbesartan—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0312	0.0666	CbGbCtD
Irbesartan—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0299	0.0638	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.022	0.0471	CbGbCtD
Irbesartan—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0217	0.0465	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0205	0.0439	CbGbCtD
Irbesartan—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0199	0.0425	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0167	0.0357	CbGbCtD
Irbesartan—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0143	0.0306	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—rheumatoid arthritis	0.0143	0.0306	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—rheumatoid arthritis	0.0141	0.0302	CbGbCtD
Irbesartan—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0134	0.0286	CbGbCtD
Irbesartan—CYP3A4—Prednisone—rheumatoid arthritis	0.0133	0.0285	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0131	0.028	CbGbCtD
Irbesartan—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0126	0.027	CbGbCtD
Irbesartan—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00833	0.0178	CbGbCtD
Irbesartan—JUN—exocrine gland—rheumatoid arthritis	0.000755	0.166	CbGeAlD
Irbesartan—JUN—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000535	0.0912	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000535	0.0912	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000505	0.0861	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000505	0.0861	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000497	0.0847	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000497	0.0847	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000486	0.0828	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000486	0.0828	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisone—rheumatoid arthritis	0.000461	0.0786	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisone—rheumatoid arthritis	0.000461	0.0786	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisolone—rheumatoid arthritis	0.00045	0.0767	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisolone—rheumatoid arthritis	0.00045	0.0767	CbGdCrCtD
Irbesartan—UGT1A3—digestive system—rheumatoid arthritis	0.000441	0.0972	CbGeAlD
Irbesartan—JUN—parotid gland—rheumatoid arthritis	0.000393	0.0865	CbGeAlD
Irbesartan—JUN—saliva-secreting gland—rheumatoid arthritis	0.000376	0.0829	CbGeAlD
Irbesartan—JUN—connective tissue—rheumatoid arthritis	0.000346	0.0762	CbGeAlD
Irbesartan—EDNRA—tendon—rheumatoid arthritis	0.000261	0.0574	CbGeAlD
Irbesartan—AGTR1—connective tissue—rheumatoid arthritis	0.00026	0.0574	CbGeAlD
Irbesartan—JUN—lymphoid tissue—rheumatoid arthritis	0.000253	0.0557	CbGeAlD
Irbesartan—JUN—digestive system—rheumatoid arthritis	0.00025	0.055	CbGeAlD
Irbesartan—JUN—tendon—rheumatoid arthritis	0.000238	0.0523	CbGeAlD
Irbesartan—AGTR1—lymphoid tissue—rheumatoid arthritis	0.00019	0.0419	CbGeAlD
Irbesartan—AGTR1—tendon—rheumatoid arthritis	0.000179	0.0394	CbGeAlD
Irbesartan—Myalgia—Betamethasone—rheumatoid arthritis	0.00013	0.000468	CcSEcCtD
Irbesartan—Myalgia—Dexamethasone—rheumatoid arthritis	0.00013	0.000468	CcSEcCtD
Irbesartan—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00013	0.000467	CcSEcCtD
Irbesartan—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00013	0.000467	CcSEcCtD
Irbesartan—Anxiety—Betamethasone—rheumatoid arthritis	0.00013	0.000467	CcSEcCtD
Irbesartan—Anxiety—Dexamethasone—rheumatoid arthritis	0.00013	0.000467	CcSEcCtD
Irbesartan—Discomfort—Betamethasone—rheumatoid arthritis	0.000129	0.000463	CcSEcCtD
Irbesartan—Discomfort—Dexamethasone—rheumatoid arthritis	0.000129	0.000463	CcSEcCtD
Irbesartan—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000128	0.000463	CcSEcCtD
Irbesartan—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000128	0.000461	CcSEcCtD
Irbesartan—Pain—Prednisolone—rheumatoid arthritis	0.000128	0.00046	CcSEcCtD
Irbesartan—Hepatitis—Methotrexate—rheumatoid arthritis	0.000128	0.00046	CcSEcCtD
Irbesartan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000127	0.000457	CcSEcCtD
Irbesartan—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000127	0.000456	CcSEcCtD
Irbesartan—Nausea—Leflunomide—rheumatoid arthritis	0.000126	0.000455	CcSEcCtD
Irbesartan—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000126	0.000454	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000126	0.000454	CcSEcCtD
Irbesartan—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000126	0.000453	CcSEcCtD
Irbesartan—Vision blurred—Prednisone—rheumatoid arthritis	0.000125	0.000452	CcSEcCtD
Irbesartan—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000125	0.000451	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000125	0.000451	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000125	0.00045	CcSEcCtD
Irbesartan—Pain—Hydrocortisone—rheumatoid arthritis	0.000125	0.000449	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000125	0.000449	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000125	0.000449	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—rheumatoid arthritis	0.000125	0.000449	CcSEcCtD
Irbesartan—Oedema—Betamethasone—rheumatoid arthritis	0.000125	0.000449	CcSEcCtD
Irbesartan—Infection—Dexamethasone—rheumatoid arthritis	0.000124	0.000446	CcSEcCtD
Irbesartan—Infection—Betamethasone—rheumatoid arthritis	0.000124	0.000446	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000123	0.000445	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000123	0.000444	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000123	0.000443	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000123	0.000443	CcSEcCtD
Irbesartan—Visual impairment—Methotrexate—rheumatoid arthritis	0.000123	0.000443	CcSEcCtD
Irbesartan—Anaemia—Prednisone—rheumatoid arthritis	0.000123	0.000443	CcSEcCtD
Irbesartan—Shock—Betamethasone—rheumatoid arthritis	0.000123	0.000442	CcSEcCtD
Irbesartan—Shock—Dexamethasone—rheumatoid arthritis	0.000123	0.000442	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000123	0.000441	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000122	0.00044	CcSEcCtD
Irbesartan—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000122	0.00044	CcSEcCtD
Irbesartan—Agitation—Prednisone—rheumatoid arthritis	0.000122	0.00044	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000122	0.00044	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000122	0.00044	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000122	0.000438	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—rheumatoid arthritis	0.000122	0.000438	CcSEcCtD
Irbesartan—Angioedema—Prednisone—rheumatoid arthritis	0.000122	0.000438	CcSEcCtD
Irbesartan—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000121	0.000436	CcSEcCtD
Irbesartan—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000121	0.000436	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000121	0.000435	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000121	0.000434	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000121	0.000434	CcSEcCtD
Irbesartan—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.00012	0.000433	CcSEcCtD
Irbesartan—Malaise—Prednisone—rheumatoid arthritis	0.00012	0.000432	CcSEcCtD
Irbesartan—Vertigo—Prednisone—rheumatoid arthritis	0.00012	0.00043	CcSEcCtD
Irbesartan—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000119	0.00043	CcSEcCtD
Irbesartan—Syncope—Prednisone—rheumatoid arthritis	0.000119	0.00043	CcSEcCtD
Irbesartan—Tinnitus—Methotrexate—rheumatoid arthritis	0.000119	0.000429	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—rheumatoid arthritis	0.000119	0.000428	CcSEcCtD
Irbesartan—Anorexia—Betamethasone—rheumatoid arthritis	0.000119	0.000428	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—rheumatoid arthritis	0.000119	0.000427	CcSEcCtD
Irbesartan—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000119	0.000427	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—rheumatoid arthritis	0.000118	0.000427	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000118	0.000426	CcSEcCtD
Irbesartan—Asthenia—Cyclosporine—rheumatoid arthritis	0.000118	0.000424	CcSEcCtD
Irbesartan—Pain—Triamcinolone—rheumatoid arthritis	0.000118	0.000423	CcSEcCtD
Irbesartan—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000117	0.000421	CcSEcCtD
Irbesartan—Hypotension—Betamethasone—rheumatoid arthritis	0.000117	0.00042	CcSEcCtD
Irbesartan—Hypotension—Dexamethasone—rheumatoid arthritis	0.000117	0.00042	CcSEcCtD
Irbesartan—Pruritus—Cyclosporine—rheumatoid arthritis	0.000116	0.000418	CcSEcCtD
Irbesartan—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000116	0.000417	CcSEcCtD
Irbesartan—Angiopathy—Methotrexate—rheumatoid arthritis	0.000116	0.000417	CcSEcCtD
Irbesartan—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000115	0.000415	CcSEcCtD
Irbesartan—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000115	0.000415	CcSEcCtD
Irbesartan—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000115	0.000415	CcSEcCtD
Irbesartan—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000115	0.000415	CcSEcCtD
Irbesartan—Hypertension—Prednisone—rheumatoid arthritis	0.000115	0.000414	CcSEcCtD
Irbesartan—Chills—Methotrexate—rheumatoid arthritis	0.000115	0.000413	CcSEcCtD
Irbesartan—PTGS1—connective tissue—rheumatoid arthritis	0.000115	0.0252	CbGeAlD
Irbesartan—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000114	0.000409	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000114	0.000409	CcSEcCtD
Irbesartan—Arthralgia—Prednisone—rheumatoid arthritis	0.000113	0.000408	CcSEcCtD
Irbesartan—Myalgia—Prednisone—rheumatoid arthritis	0.000113	0.000408	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000113	0.000408	CcSEcCtD
Irbesartan—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000113	0.000407	CcSEcCtD
Irbesartan—Anxiety—Prednisone—rheumatoid arthritis	0.000113	0.000406	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000112	0.000405	CcSEcCtD
Irbesartan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000112	0.000405	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000112	0.000404	CcSEcCtD
Irbesartan—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000112	0.000403	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000112	0.000403	CcSEcCtD
Irbesartan—Discomfort—Prednisone—rheumatoid arthritis	0.000112	0.000403	CcSEcCtD
Irbesartan—Erythema—Methotrexate—rheumatoid arthritis	0.000111	0.0004	CcSEcCtD
Irbesartan—Malnutrition—Methotrexate—rheumatoid arthritis	0.000111	0.0004	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00011	0.000396	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.00011	0.000395	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—rheumatoid arthritis	0.00011	0.000395	CcSEcCtD
Irbesartan—Urticaria—Triamcinolone—rheumatoid arthritis	0.000109	0.000393	CcSEcCtD
Irbesartan—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000109	0.000392	CcSEcCtD
Irbesartan—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000109	0.000392	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000109	0.000391	CcSEcCtD
Irbesartan—Dizziness—Cyclosporine—rheumatoid arthritis	0.000109	0.000391	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000109	0.000391	CcSEcCtD
Irbesartan—Oedema—Prednisone—rheumatoid arthritis	0.000109	0.000391	CcSEcCtD
Irbesartan—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000108	0.00039	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000108	0.00039	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000108	0.00039	CcSEcCtD
Irbesartan—Infection—Prednisone—rheumatoid arthritis	0.000108	0.000388	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000108	0.000388	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000108	0.000388	CcSEcCtD
Irbesartan—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000108	0.000387	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—rheumatoid arthritis	0.000107	0.000387	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—rheumatoid arthritis	0.000107	0.000387	CcSEcCtD
Irbesartan—Shock—Prednisone—rheumatoid arthritis	0.000107	0.000385	CcSEcCtD
Irbesartan—Pain—Dexamethasone—rheumatoid arthritis	0.000107	0.000384	CcSEcCtD
Irbesartan—Pain—Betamethasone—rheumatoid arthritis	0.000107	0.000384	CcSEcCtD
Irbesartan—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000106	0.000383	CcSEcCtD
Irbesartan—Tachycardia—Prednisone—rheumatoid arthritis	0.000106	0.000382	CcSEcCtD
Irbesartan—Skin disorder—Prednisone—rheumatoid arthritis	0.000105	0.00038	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000105	0.000378	CcSEcCtD
Irbesartan—Vision blurred—Methotrexate—rheumatoid arthritis	0.000105	0.000377	CcSEcCtD
Irbesartan—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000105	0.000377	CcSEcCtD
Irbesartan—Vomiting—Cyclosporine—rheumatoid arthritis	0.000104	0.000376	CcSEcCtD
Irbesartan—Rash—Cyclosporine—rheumatoid arthritis	0.000104	0.000373	CcSEcCtD
Irbesartan—Anorexia—Prednisone—rheumatoid arthritis	0.000103	0.000373	CcSEcCtD
Irbesartan—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000103	0.000372	CcSEcCtD
Irbesartan—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000103	0.000372	CcSEcCtD
Irbesartan—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000103	0.000371	CcSEcCtD
Irbesartan—Headache—Cyclosporine—rheumatoid arthritis	0.000103	0.00037	CcSEcCtD
Irbesartan—Anaemia—Methotrexate—rheumatoid arthritis	0.000103	0.00037	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000103	0.00037	CcSEcCtD
Irbesartan—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000103	0.00037	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000102	0.000367	CcSEcCtD
Irbesartan—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000102	0.000367	CcSEcCtD
Irbesartan—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000101	0.000365	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000101	0.000364	CcSEcCtD
Irbesartan—Malaise—Methotrexate—rheumatoid arthritis	0.0001	0.000361	CcSEcCtD
Irbesartan—Vertigo—Methotrexate—rheumatoid arthritis	9.99e-05	0.00036	CcSEcCtD
Irbesartan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9.98e-05	0.00036	CcSEcCtD
Irbesartan—Leukopenia—Methotrexate—rheumatoid arthritis	9.95e-05	0.000358	CcSEcCtD
Irbesartan—Urticaria—Dexamethasone—rheumatoid arthritis	9.9e-05	0.000357	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—rheumatoid arthritis	9.9e-05	0.000357	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	9.89e-05	0.000356	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—rheumatoid arthritis	9.88e-05	0.000356	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—rheumatoid arthritis	9.86e-05	0.000355	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—rheumatoid arthritis	9.86e-05	0.000355	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—rheumatoid arthritis	9.86e-05	0.000355	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—rheumatoid arthritis	9.86e-05	0.000355	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—rheumatoid arthritis	9.86e-05	0.000355	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—rheumatoid arthritis	9.84e-05	0.000354	CcSEcCtD
Irbesartan—Nausea—Cyclosporine—rheumatoid arthritis	9.75e-05	0.000351	CcSEcCtD
Irbesartan—Paraesthesia—Prednisone—rheumatoid arthritis	9.75e-05	0.000351	CcSEcCtD
Irbesartan—Pruritus—Triamcinolone—rheumatoid arthritis	9.72e-05	0.00035	CcSEcCtD
Irbesartan—Cough—Methotrexate—rheumatoid arthritis	9.7e-05	0.000349	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—rheumatoid arthritis	9.7e-05	0.000349	CcSEcCtD
Irbesartan—Dizziness—Hydrocortisone—rheumatoid arthritis	9.65e-05	0.000348	CcSEcCtD
Irbesartan—Dyspepsia—Prednisone—rheumatoid arthritis	9.56e-05	0.000344	CcSEcCtD
Irbesartan—CYP1A2—digestive system—rheumatoid arthritis	9.55e-05	0.021	CbGeAlD
Irbesartan—Myalgia—Methotrexate—rheumatoid arthritis	9.47e-05	0.000341	CcSEcCtD
Irbesartan—Arthralgia—Methotrexate—rheumatoid arthritis	9.47e-05	0.000341	CcSEcCtD
Irbesartan—Chest pain—Methotrexate—rheumatoid arthritis	9.47e-05	0.000341	CcSEcCtD
Irbesartan—Decreased appetite—Prednisone—rheumatoid arthritis	9.44e-05	0.00034	CcSEcCtD
Irbesartan—Rash—Prednisolone—rheumatoid arthritis	9.42e-05	0.000339	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—rheumatoid arthritis	9.41e-05	0.000339	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.4e-05	0.000339	CcSEcCtD
Irbesartan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.38e-05	0.000338	CcSEcCtD
Irbesartan—Fatigue—Prednisone—rheumatoid arthritis	9.36e-05	0.000337	CcSEcCtD
Irbesartan—Headache—Prednisolone—rheumatoid arthritis	9.36e-05	0.000337	CcSEcCtD
Irbesartan—Discomfort—Methotrexate—rheumatoid arthritis	9.35e-05	0.000337	CcSEcCtD
Irbesartan—Constipation—Prednisone—rheumatoid arthritis	9.29e-05	0.000334	CcSEcCtD
Irbesartan—Vomiting—Hydrocortisone—rheumatoid arthritis	9.28e-05	0.000334	CcSEcCtD
Irbesartan—Rash—Hydrocortisone—rheumatoid arthritis	9.2e-05	0.000331	CcSEcCtD
Irbesartan—Dermatitis—Hydrocortisone—rheumatoid arthritis	9.19e-05	0.000331	CcSEcCtD
Irbesartan—Headache—Hydrocortisone—rheumatoid arthritis	9.14e-05	0.000329	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—rheumatoid arthritis	9.09e-05	0.000327	CcSEcCtD
Irbesartan—Anaphylactic shock—Methotrexate—rheumatoid arthritis	9.07e-05	0.000327	CcSEcCtD
Irbesartan—Dizziness—Methylprednisolone—rheumatoid arthritis	9.07e-05	0.000326	CcSEcCtD
Irbesartan—CYP2C9—digestive system—rheumatoid arthritis	9.06e-05	0.0199	CbGeAlD
Irbesartan—Infection—Methotrexate—rheumatoid arthritis	9.01e-05	0.000325	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisone—rheumatoid arthritis	8.95e-05	0.000322	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—rheumatoid arthritis	8.95e-05	0.000322	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—rheumatoid arthritis	8.95e-05	0.000322	CcSEcCtD
Irbesartan—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.9e-05	0.00032	CcSEcCtD
Irbesartan—Thrombocytopenia—Methotrexate—rheumatoid arthritis	8.88e-05	0.00032	CcSEcCtD
Irbesartan—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8.88e-05	0.00032	CcSEcCtD
Irbesartan—Nausea—Prednisolone—rheumatoid arthritis	8.88e-05	0.00032	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—rheumatoid arthritis	8.82e-05	0.000318	CcSEcCtD
Irbesartan—Pruritus—Dexamethasone—rheumatoid arthritis	8.82e-05	0.000318	CcSEcCtD
Irbesartan—Skin disorder—Methotrexate—rheumatoid arthritis	8.81e-05	0.000317	CcSEcCtD
Irbesartan—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.77e-05	0.000316	CcSEcCtD
Irbesartan—Vomiting—Triamcinolone—rheumatoid arthritis	8.74e-05	0.000315	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—rheumatoid arthritis	8.72e-05	0.000314	CcSEcCtD
Irbesartan—Nausea—Hydrocortisone—rheumatoid arthritis	8.67e-05	0.000312	CcSEcCtD
Irbesartan—Rash—Triamcinolone—rheumatoid arthritis	8.66e-05	0.000312	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—rheumatoid arthritis	8.66e-05	0.000312	CcSEcCtD
Irbesartan—Anorexia—Methotrexate—rheumatoid arthritis	8.65e-05	0.000311	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—rheumatoid arthritis	8.64e-05	0.000311	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—rheumatoid arthritis	8.64e-05	0.000311	CcSEcCtD
Irbesartan—Urticaria—Prednisone—rheumatoid arthritis	8.63e-05	0.000311	CcSEcCtD
Irbesartan—Headache—Triamcinolone—rheumatoid arthritis	8.61e-05	0.00031	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—rheumatoid arthritis	8.59e-05	0.000309	CcSEcCtD
Irbesartan—Abdominal pain—Prednisone—rheumatoid arthritis	8.58e-05	0.000309	CcSEcCtD
Irbesartan—Body temperature increased—Prednisone—rheumatoid arthritis	8.58e-05	0.000309	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—rheumatoid arthritis	8.53e-05	0.000307	CcSEcCtD
Irbesartan—Diarrhoea—Dexamethasone—rheumatoid arthritis	8.53e-05	0.000307	CcSEcCtD
Irbesartan—Hypotension—Methotrexate—rheumatoid arthritis	8.48e-05	0.000305	CcSEcCtD
Irbesartan—PTGS1—digestive system—rheumatoid arthritis	8.27e-05	0.0182	CbGeAlD
Irbesartan—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	8.27e-05	0.000298	CcSEcCtD
Irbesartan—Dizziness—Dexamethasone—rheumatoid arthritis	8.24e-05	0.000297	CcSEcCtD
Irbesartan—Dizziness—Betamethasone—rheumatoid arthritis	8.24e-05	0.000297	CcSEcCtD
Irbesartan—Nausea—Triamcinolone—rheumatoid arthritis	8.16e-05	0.000294	CcSEcCtD
Irbesartan—Paraesthesia—Methotrexate—rheumatoid arthritis	8.15e-05	0.000293	CcSEcCtD
Irbesartan—Nausea—Methylprednisolone—rheumatoid arthritis	8.14e-05	0.000293	CcSEcCtD
Irbesartan—Dyspnoea—Methotrexate—rheumatoid arthritis	8.09e-05	0.000291	CcSEcCtD
Irbesartan—Somnolence—Methotrexate—rheumatoid arthritis	8.07e-05	0.00029	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisone—rheumatoid arthritis	8e-05	0.000288	CcSEcCtD
Irbesartan—Dyspepsia—Methotrexate—rheumatoid arthritis	7.99e-05	0.000288	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—rheumatoid arthritis	7.93e-05	0.000285	CcSEcCtD
Irbesartan—Vomiting—Betamethasone—rheumatoid arthritis	7.93e-05	0.000285	CcSEcCtD
Irbesartan—Decreased appetite—Methotrexate—rheumatoid arthritis	7.89e-05	0.000284	CcSEcCtD
Irbesartan—PTGS1—tendon—rheumatoid arthritis	7.87e-05	0.0173	CbGeAlD
Irbesartan—Rash—Dexamethasone—rheumatoid arthritis	7.86e-05	0.000283	CcSEcCtD
Irbesartan—Rash—Betamethasone—rheumatoid arthritis	7.86e-05	0.000283	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—rheumatoid arthritis	7.85e-05	0.000283	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—rheumatoid arthritis	7.85e-05	0.000283	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.83e-05	0.000282	CcSEcCtD
Irbesartan—Fatigue—Methotrexate—rheumatoid arthritis	7.82e-05	0.000282	CcSEcCtD
Irbesartan—Headache—Betamethasone—rheumatoid arthritis	7.81e-05	0.000281	CcSEcCtD
Irbesartan—Headache—Dexamethasone—rheumatoid arthritis	7.81e-05	0.000281	CcSEcCtD
Irbesartan—Asthenia—Prednisone—rheumatoid arthritis	7.79e-05	0.000281	CcSEcCtD
Irbesartan—Pain—Methotrexate—rheumatoid arthritis	7.76e-05	0.000279	CcSEcCtD
Irbesartan—Pruritus—Prednisone—rheumatoid arthritis	7.68e-05	0.000277	CcSEcCtD
Irbesartan—Feeling abnormal—Methotrexate—rheumatoid arthritis	7.48e-05	0.000269	CcSEcCtD
Irbesartan—Diarrhoea—Prednisone—rheumatoid arthritis	7.43e-05	0.000268	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	7.42e-05	0.000267	CcSEcCtD
Irbesartan—Nausea—Betamethasone—rheumatoid arthritis	7.41e-05	0.000267	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—rheumatoid arthritis	7.41e-05	0.000267	CcSEcCtD
Irbesartan—Urticaria—Methotrexate—rheumatoid arthritis	7.21e-05	0.00026	CcSEcCtD
Irbesartan—Dizziness—Prednisone—rheumatoid arthritis	7.18e-05	0.000259	CcSEcCtD
Irbesartan—Abdominal pain—Methotrexate—rheumatoid arthritis	7.17e-05	0.000258	CcSEcCtD
Irbesartan—Body temperature increased—Methotrexate—rheumatoid arthritis	7.17e-05	0.000258	CcSEcCtD
Irbesartan—CYP3A4—digestive system—rheumatoid arthritis	6.91e-05	0.0152	CbGeAlD
Irbesartan—Vomiting—Prednisone—rheumatoid arthritis	6.9e-05	0.000249	CcSEcCtD
Irbesartan—Rash—Prednisone—rheumatoid arthritis	6.85e-05	0.000247	CcSEcCtD
Irbesartan—Dermatitis—Prednisone—rheumatoid arthritis	6.84e-05	0.000246	CcSEcCtD
Irbesartan—Headache—Prednisone—rheumatoid arthritis	6.8e-05	0.000245	CcSEcCtD
Irbesartan—CYP2D6—digestive system—rheumatoid arthritis	6.8e-05	0.015	CbGeAlD
Irbesartan—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.69e-05	0.000241	CcSEcCtD
Irbesartan—Asthenia—Methotrexate—rheumatoid arthritis	6.51e-05	0.000234	CcSEcCtD
Irbesartan—Nausea—Prednisone—rheumatoid arthritis	6.45e-05	0.000232	CcSEcCtD
Irbesartan—Pruritus—Methotrexate—rheumatoid arthritis	6.42e-05	0.000231	CcSEcCtD
Irbesartan—Diarrhoea—Methotrexate—rheumatoid arthritis	6.21e-05	0.000224	CcSEcCtD
Irbesartan—Dizziness—Methotrexate—rheumatoid arthritis	6e-05	0.000216	CcSEcCtD
Irbesartan—Vomiting—Methotrexate—rheumatoid arthritis	5.77e-05	0.000208	CcSEcCtD
Irbesartan—Rash—Methotrexate—rheumatoid arthritis	5.72e-05	0.000206	CcSEcCtD
Irbesartan—Dermatitis—Methotrexate—rheumatoid arthritis	5.72e-05	0.000206	CcSEcCtD
Irbesartan—Headache—Methotrexate—rheumatoid arthritis	5.68e-05	0.000205	CcSEcCtD
Irbesartan—Nausea—Methotrexate—rheumatoid arthritis	5.39e-05	0.000194	CcSEcCtD
Irbesartan—CYP2C8—Metabolism—SLC25A12—rheumatoid arthritis	2.28e-05	9.32e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SPP1—rheumatoid arthritis	2.26e-05	9.28e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTK2—rheumatoid arthritis	2.26e-05	9.26e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT1—rheumatoid arthritis	2.26e-05	9.26e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.25e-05	9.24e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CAT—rheumatoid arthritis	2.24e-05	9.18e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	2.24e-05	9.17e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	2.23e-05	9.14e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	2.23e-05	9.13e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1A—rheumatoid arthritis	2.22e-05	9.1e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—rheumatoid arthritis	2.22e-05	9.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL2—rheumatoid arthritis	2.22e-05	9.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL3—rheumatoid arthritis	2.22e-05	9.08e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	2.21e-05	9.07e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGES—rheumatoid arthritis	2.21e-05	9.06e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GC—rheumatoid arthritis	2.21e-05	9.06e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—rheumatoid arthritis	2.21e-05	9.05e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—rheumatoid arthritis	2.2e-05	9.02e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—rheumatoid arthritis	2.18e-05	8.95e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CSF2—rheumatoid arthritis	2.18e-05	8.95e-05	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—rheumatoid arthritis	2.18e-05	8.92e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2RA—rheumatoid arthritis	2.17e-05	8.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.17e-05	8.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SAA1—rheumatoid arthritis	2.17e-05	8.88e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—rheumatoid arthritis	2.15e-05	8.83e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—rheumatoid arthritis	2.15e-05	8.82e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—C3—rheumatoid arthritis	2.15e-05	8.82e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	2.15e-05	8.81e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AGER—rheumatoid arthritis	2.13e-05	8.72e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NCF1—rheumatoid arthritis	2.12e-05	8.69e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-B—rheumatoid arthritis	2.1e-05	8.61e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLB1—rheumatoid arthritis	2.06e-05	8.43e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	2.06e-05	8.42e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD28—rheumatoid arthritis	2.04e-05	8.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	2.04e-05	8.35e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP3—rheumatoid arthritis	2.03e-05	8.33e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	2.03e-05	8.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	2.02e-05	8.26e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LEP—rheumatoid arthritis	2e-05	8.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	1.99e-05	8.14e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	1.97e-05	8.07e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2RA—rheumatoid arthritis	1.97e-05	8.06e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTK2—rheumatoid arthritis	1.96e-05	8.02e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—C3—rheumatoid arthritis	1.95e-05	8e-05	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.95e-05	7.98e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-A—rheumatoid arthritis	1.95e-05	7.97e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.92e-05	7.87e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL5—rheumatoid arthritis	1.92e-05	7.86e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.89e-05	7.75e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FN1—rheumatoid arthritis	1.89e-05	7.74e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CSF2—rheumatoid arthritis	1.89e-05	7.74e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.88e-05	7.72e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL12—rheumatoid arthritis	1.88e-05	7.72e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6ST—rheumatoid arthritis	1.88e-05	7.71e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—rheumatoid arthritis	1.87e-05	7.66e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	1.87e-05	7.65e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.86e-05	7.63e-05	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.86e-05	7.63e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—rheumatoid arthritis	1.86e-05	7.61e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKB1—rheumatoid arthritis	1.86e-05	7.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	1.85e-05	7.58e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MAPK8—rheumatoid arthritis	1.82e-05	7.47e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	1.82e-05	7.44e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GC—rheumatoid arthritis	1.82e-05	7.44e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD80—rheumatoid arthritis	1.81e-05	7.42e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MED1—rheumatoid arthritis	1.8e-05	7.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GC—rheumatoid arthritis	1.8e-05	7.38e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	1.8e-05	7.38e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—rheumatoid arthritis	1.78e-05	7.29e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—rheumatoid arthritis	1.78e-05	7.28e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SPP1—rheumatoid arthritis	1.78e-05	7.28e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.77e-05	7.25e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.76e-05	7.2e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ENO1—rheumatoid arthritis	1.75e-05	7.18e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SYK—rheumatoid arthritis	1.75e-05	7.18e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	1.74e-05	7.14e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—rheumatoid arthritis	1.73e-05	7.08e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.73e-05	7.07e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—rheumatoid arthritis	1.72e-05	7.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.72e-05	7.04e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.71e-05	7e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—rheumatoid arthritis	1.71e-05	6.99e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6ST—rheumatoid arthritis	1.71e-05	6.99e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.7e-05	6.98e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—rheumatoid arthritis	1.69e-05	6.93e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—rheumatoid arthritis	1.69e-05	6.92e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT1—rheumatoid arthritis	1.69e-05	6.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	1.69e-05	6.92e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—rheumatoid arthritis	1.68e-05	6.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	1.68e-05	6.89e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6R—rheumatoid arthritis	1.68e-05	6.88e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—B3GNT2—rheumatoid arthritis	1.68e-05	6.87e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ACP5—rheumatoid arthritis	1.68e-05	6.87e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	1.67e-05	6.86e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—rheumatoid arthritis	1.67e-05	6.82e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD80—rheumatoid arthritis	1.64e-05	6.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	1.58e-05	6.48e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LEP—rheumatoid arthritis	1.57e-05	6.44e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GC—rheumatoid arthritis	1.54e-05	6.3e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	1.54e-05	6.3e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TYK2—rheumatoid arthritis	1.53e-05	6.27e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6R—rheumatoid arthritis	1.52e-05	6.24e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP3—rheumatoid arthritis	1.52e-05	6.22e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—BGN—rheumatoid arthritis	1.51e-05	6.19e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.51e-05	6.18e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—rheumatoid arthritis	1.5e-05	6.15e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—rheumatoid arthritis	1.5e-05	6.13e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FN1—rheumatoid arthritis	1.48e-05	6.08e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MED1—rheumatoid arthritis	1.48e-05	6.07e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.48e-05	6.05e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.47e-05	6.01e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTK2—rheumatoid arthritis	1.46e-05	5.99e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL5—rheumatoid arthritis	1.43e-05	5.87e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	1.43e-05	5.86e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD80—rheumatoid arthritis	1.42e-05	5.82e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CSF2—rheumatoid arthritis	1.41e-05	5.78e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	1.39e-05	5.69e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—TYK2—rheumatoid arthritis	1.39e-05	5.68e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	1.38e-05	5.64e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	1.38e-05	5.64e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.37e-05	5.59e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.37e-05	5.59e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—rheumatoid arthritis	1.36e-05	5.59e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—rheumatoid arthritis	1.35e-05	5.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.34e-05	5.51e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—rheumatoid arthritis	1.33e-05	5.46e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SPP1—rheumatoid arthritis	1.33e-05	5.44e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—rheumatoid arthritis	1.32e-05	5.41e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6R—rheumatoid arthritis	1.32e-05	5.4e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—rheumatoid arthritis	1.3e-05	5.34e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—rheumatoid arthritis	1.3e-05	5.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.3e-05	5.32e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—rheumatoid arthritis	1.29e-05	5.29e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—rheumatoid arthritis	1.27e-05	5.21e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2RA—rheumatoid arthritis	1.27e-05	5.21e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—rheumatoid arthritis	1.27e-05	5.19e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—rheumatoid arthritis	1.26e-05	5.17e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—rheumatoid arthritis	1.26e-05	5.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MED1—rheumatoid arthritis	1.25e-05	5.14e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—rheumatoid arthritis	1.25e-05	5.14e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—BGN—rheumatoid arthritis	1.24e-05	5.08e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—BGN—rheumatoid arthritis	1.23e-05	5.03e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.22e-05	5.01e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.22e-05	5e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—rheumatoid arthritis	1.2e-05	4.93e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TYK2—rheumatoid arthritis	1.2e-05	4.92e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—rheumatoid arthritis	1.19e-05	4.89e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKB1—rheumatoid arthritis	1.19e-05	4.88e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.19e-05	4.87e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.19e-05	4.87e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—rheumatoid arthritis	1.18e-05	4.83e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—rheumatoid arthritis	1.18e-05	4.81e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK8—rheumatoid arthritis	1.17e-05	4.8e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	1.17e-05	4.78e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	1.17e-05	4.78e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—rheumatoid arthritis	1.16e-05	4.77e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—rheumatoid arthritis	1.16e-05	4.75e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—rheumatoid arthritis	1.15e-05	4.73e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	1.14e-05	4.67e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	1.13e-05	4.64e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1.13e-05	4.63e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.11e-05	4.56e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FN1—rheumatoid arthritis	1.11e-05	4.54e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.1e-05	4.52e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6ST—rheumatoid arthritis	1.1e-05	4.52e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—rheumatoid arthritis	1.08e-05	4.43e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKB1—rheumatoid arthritis	1.08e-05	4.43e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK8—rheumatoid arthritis	1.06e-05	4.35e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD80—rheumatoid arthritis	1.06e-05	4.35e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	1.05e-05	4.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BGN—rheumatoid arthritis	1.05e-05	4.3e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.05e-05	4.28e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—rheumatoid arthritis	1.01e-05	4.13e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—rheumatoid arthritis	9.99e-06	4.09e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.95e-06	4.07e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—rheumatoid arthritis	9.94e-06	4.07e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—rheumatoid arthritis	9.93e-06	4.07e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—rheumatoid arthritis	9.88e-06	4.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6R—rheumatoid arthritis	9.85e-06	4.03e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	9.75e-06	3.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MED1—rheumatoid arthritis	9.68e-06	3.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	9.67e-06	3.96e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—rheumatoid arthritis	9.45e-06	3.87e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	9.35e-06	3.83e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	9.3e-06	3.81e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	9.22e-06	3.78e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	9.19e-06	3.77e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9.07e-06	3.71e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	9e-06	3.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	9e-06	3.69e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TYK2—rheumatoid arthritis	8.97e-06	3.67e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—rheumatoid arthritis	8.8e-06	3.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.5e-06	3.48e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	8.49e-06	3.48e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—rheumatoid arthritis	8.43e-06	3.45e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—rheumatoid arthritis	8.17e-06	3.35e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—rheumatoid arthritis	8.16e-06	3.34e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BGN—rheumatoid arthritis	8.11e-06	3.32e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.93e-06	3.25e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	7.88e-06	3.23e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—rheumatoid arthritis	7.81e-06	3.2e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.79e-06	3.19e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	7.75e-06	3.17e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—rheumatoid arthritis	7.68e-06	3.15e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—rheumatoid arthritis	7.48e-06	3.06e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—rheumatoid arthritis	7.46e-06	3.06e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	7.46e-06	3.06e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—rheumatoid arthritis	7.35e-06	3.01e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—rheumatoid arthritis	7.06e-06	2.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKB1—rheumatoid arthritis	6.99e-06	2.86e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK8—rheumatoid arthritis	6.87e-06	2.81e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	6.81e-06	2.79e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—rheumatoid arthritis	6.78e-06	2.78e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	6.78e-06	2.78e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	6.72e-06	2.75e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—rheumatoid arthritis	6.7e-06	2.74e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—rheumatoid arthritis	6.64e-06	2.72e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—rheumatoid arthritis	6.41e-06	2.63e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—rheumatoid arthritis	6.34e-06	2.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	6.08e-06	2.49e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—rheumatoid arthritis	5.87e-06	2.4e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—rheumatoid arthritis	5.82e-06	2.38e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—rheumatoid arthritis	5.67e-06	2.32e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	5.59e-06	2.29e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	5.54e-06	2.27e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—rheumatoid arthritis	5.44e-06	2.23e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—rheumatoid arthritis	4.96e-06	2.03e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—rheumatoid arthritis	4.79e-06	1.96e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	4.75e-06	1.94e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	4.73e-06	1.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—rheumatoid arthritis	4.47e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—rheumatoid arthritis	4.43e-06	1.81e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—rheumatoid arthritis	4.39e-06	1.8e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.38e-06	1.79e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	4.34e-06	1.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—rheumatoid arthritis	4.07e-06	1.67e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—rheumatoid arthritis	4.04e-06	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.9e-06	1.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	3.86e-06	1.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—rheumatoid arthritis	3.79e-06	1.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.65e-06	1.5e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	3.56e-06	1.46e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	3.53e-06	1.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—rheumatoid arthritis	3.45e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	3.3e-06	1.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	3.02e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.92e-06	1.2e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.66e-06	1.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.55e-06	1.04e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.33e-06	9.55e-06	CbGpPWpGaD
